Virnetx Holding Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Quarterly Report (Form 10-Q) | 13 Nov 2026 |
| FY 2026 Annual Report (Form 10-K) | 24 Mar 2027 |
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly0.0Target: Commercialization of iSCOUT and GSA Schedule contracts to generate recurring software revenue
Quarterly Net Loss Quarterly-4.4MTarget: Reduction of operating expenses to achieve cash flow break-even
Total Cash, Cash Equivalents, and Short-term Investments Quarterly17.2MTarget: Maintain sufficient liquidity to extend runway beyond Q2 2027
Watch Items
- Going Concern Status and Cash RunwayTrigger: Cash and short-term investments falling below $10 million without new capital or revenueAction: Accelerate capital raising under the S-3 shelf registration or implement aggressive cost-cutting measures.
- Commercial Adoption of iSCOUT PlatformTrigger: Failure to secure commercial or public-sector contracts within 6 months of the June 2026 launchAction: Re-evaluate product-market fit, pricing strategy, and sales channel partnerships.
- Dilution from Equity OfferingsTrigger: Utilization of the $20 million S-3 shelf registration statementAction: Assess the impact of share dilution on existing stockholders and monitor the 2013 Equity Incentive Plan reserve.
Research as of 19 Jun 2026